Table 3.

Multivariate analysis of OS in patients with KRAS-mutant NSCLC

VariableHR (95% CI)P
TP53 (+ vs. −)1.11 (0.77–1.58)0.581
STK11 (+ vs. −)1.30 (0.86–1.97)0.216
KEAP1/NFE2L2 (+/−)1.96 (1.33–2.92)<0.001
Gender (male vs. female)1.20 (0.86–1.68)0.284
Age at diagnosis1.03 (1.01–1.05)0.003
Smoking (former/current vs. never)1.43 (0.86–1.68)0.402
KPS at diagnosis (KPS 80–100 vs. <80)0.88 (0.60–1.29)0.514